BIOLOGICAL ROLE OF HGF/MET PATHWAY IN RENAL CELL CARCINOMA
Authors:
- Shigeo HorieSHShigeo Horie
- Seiji ArugaSASeiji Aruga
- Hitoshi KawamataHKHitoshi Kawamata
- Nobuo OkuiNONobuo Okui
- Tadao KakizoeTKTadao Kakizoe
- Tadaichi KitamuraTKTadaichi Kitamura
- 1 March 1999
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 161 (3) , 990-997
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- C-Met Proto-Oncogene Expression in Benign and Malignant Human Renal TissuesJournal of Urology, 1997
- Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphateNature, 1996
- Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase aInternational Journal of Cancer, 1995
- Tumor-stroma interactions and stromal cell density regulate hepatocyte growth factor protein levels: a role for transforming growth factor- beta activationEndocrinology, 1995
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Immunohistochemical Detection of Hepatocyte Growth Factor/Scatter Factor in Human Cancerous and Inflammatory Lesions of Various OrgansJapanese Journal of Cancer Research, 1993
- Tumor Size of Renal Cell Carcinoma: Its Clinical ImplicationUrologia Internationalis, 1992
- Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factorCell, 1991
- Molecular cloning and expression of human hepatocyte growth factorNature, 1989